Possible predictor | Criteria | Odds ratio (Expo [β]) | p-value | Bonferroni holm corrected p-value1 |
---|---|---|---|---|
Age | treatment group | 0.398 | 0.413 | 0.007 |
subtype | 0.360 | 0.431 | 0.008 | |
subtype*group | 1.013 | 0.673 | 0.017 | |
Sex | treatment group | 0.398 | 0.457 | 0.010 |
subtype | 0.760 | 0.807 | 0.050 | |
subtype*group | 1.303 | 0.724 | 0.025 | |
Age of onset | treatment group | 0.228 | 0.159 | 0.005 |
subtype | 0.952 | 0.329 | 0.006 | |
subtype*group | 1.033 | 0.318 | 0.006 | |
Prior medication | treatment group | 1.481 | 0.484 | 0.013 |
subtype | 7.600 | 0.087 | 0.005 | |
subtype*group | 0.183 | 0.031 | 0.004 | |
Course of depression (1. episode/recurrent MDD) | treatment group | 0.325 | 0.029 | 0.017 |
subtype | 0.229 | 0.229 | 0.050 | |
subtype*group | 0.061 | 0.041 | 0.025 | |
Melancholic MDD | treatment group | 0.962 | 0.956 | 0.050 |
subtype | 1.337 | 0.820 | 0.013 | |
subtype*group | 0.539 | 0.460 | 0.006 | |
Anxious depression | treatment group | 0.700 | 0.532 | 0.007 |
subtype | 0.795 | 0.839 | 0.017 | |
subtype*group | 0.785 | 0.748 | 0.010 | |
Atypical MDD | treatment group | 0.275 | 0.019 | 0.004 |
subtype | 0.174 | 0.174 | 0.005 | |
subtype*group | 5.339 | 0.032 | 0.005 | |
MDD with Suicidality | treatment group | 0.933 | 0.922 | 0.025 |
subtype | 1.620 | 0.713 | 0.008 | |
subtype*group | 0.518 | 0.430 | 0.006 | |
Comorbid axis I disorder | treatment group | 0.491 | 0.202 | 0.008 |
subtype | 0.712 | 0.761 | 0.025 | |
subtype*group | 0.617 | 0.617 | 0.017 | |
Comorbid axis II disorder | treatment group | 0.561 | 0.195 | 0.007 |
subtype | 0.489 | 0.551 | 0.013 | |
subtype*group | 1.084 | 0.921 | 0.050 | |
CIRS sum score | treatment group | 1.601 | 0.506 | 0.010 |
subtype | 1.352 | 0.175 | 0.006 | |
subtype*group | 0.778 | 0.119 | 0.006 |